David Ross

David Ross

Senior Director, Business Development

Business Development
About

David Ross has around 20 years of career experience within the pharmaceutical industry across various disciplines, sectors, and therapeutic areas.

This has included roles across Research, Project Management and Business Development within CROs, CDMOs and Pharma companies.

David holds a degree in Pharmacology from Newcastle University.

He has represented Quotient Sciences in a Business Development role across Europe for the past 10 years, supporting customers with integrated drug product and clinical services.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More